AI assistant
Medicus Pharma Ltd. — Director's Dealing 2024
Dec 31, 2024
34562_dirs_2024-12-31_5e063e63-3245-4d18-86f6-8a5d04f34ec9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31
Reporting Person: Quinlan James P. (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares, no par value ("Common Shares") | 129147 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.81 | 2028-10-24 | Common Shares (125000) | Direct | |
| Stock Option (right to buy) | $2.75 | 2029-12-17 | Common Shares (20000) | Direct | |
| Warrants (right to buy) | $4.64 | 2029-11-15 | Common Shares (24000) | Direct |
Footnotes
F1: The option has vested and is exercisable as of the date hereof.
F2: Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
F3: The option was granted on December 17, 2024. The option is scheduled to vest quarterly in four equal installments over one year.
F4: Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
F5: The warrants are exercisable as of the date hereof.